市場調查報告書
商品編碼
1466582
膠囊內視鏡市場:依產品、應用和最終用途 – 2024-2030 年全球預測Capsule Endoscopy Market by Product (Capsule Endoscopes, Systems), Application (Crohn's Disease, Obscure Gastrointestinal Bleeding, Small Intestine Tumor), End-Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年膠囊內視鏡市場規模為5.5466億美元,2024年將達到6.0657億美元,2030年將達到10.6737億美元,複合年成長率為9.80%。
膠囊內視鏡是一種現代診斷工具,可以使用配備攝影機的錠劑大小的膠囊對胃腸道進行可視化和檢查。該市場由製造商、醫療保健提供者和使用這些設備進行胃腸道診斷的患者組成。全球胃腸道疾病盛行率的不斷上升以及微創手術干預措施的大量採用,為市場成長做出了積極貢獻。與膠囊滯留、副作用和小腸測試結果不完整相關的擔憂是市場的主要障礙。這個市場的機會包括不斷改善醫療基礎設施和提高對胃腸道疾病的認知的舉措。除了技術進步之外,設計更好的無線膠囊預計將推動市場成長。
主要市場統計 | |
---|---|
基準年[2023] | 55466萬美元 |
預測年份 [2024] | 60657萬美元 |
預測年份 [2030] | 10.6737 億美元 |
複合年成長率(%) | 9.80% |
由於微創產品,膠囊內視鏡的採用範圍不斷擴大
膠囊內視鏡是一種小型相機,其大小與患者吞嚥的錠劑大小相同。這些設備穿過胃腸道,拍攝影像並無線傳輸以進行醫療診斷。它是首選,因為它可以使小腸可視化,這是傳統內視鏡難以到達的。患者選擇膠囊內視鏡檢查是因為它是微創且不需要鎮靜。手術簡便且無不適感是其主要優點,也適合兒童和老年患者。膠囊內視鏡所使用的系統是指記錄、檢視和分析膠囊內視鏡所捕捉的資料所需的硬體和軟體。這樣的系統由工作站、資料記錄器、接收帶和影像分析軟體所組成。這些對於收集和管理膠囊內視鏡檢查產生的大量資料至關重要。先進的軟體有助於詳細檢查影像並支援更好的診斷。使用者友善的介面因其簡化內視鏡檢查過程而受到醫療保健提供者的重視。
應用 擴大膠囊內視鏡在不明原因消化道出血(OGIB) 治療的應用
克隆氏症是一種發炎性腸道疾病(IBD),可影響胃腸道的任何部位。膠囊內視鏡在診斷和評估克隆氏症的程度和活動性方面特別有用,因為它可以可視化傳統內視鏡難以到達的小腸區域。膠囊內視鏡是非侵入性的,使其成為對患者更友善的選擇,可以持續監測疾病進展和治療反應。不明原因消化道出血(OGIB)是指胃腸道內不明原因的出血。膠囊內視鏡檢查對於診斷 OGIB 極為重要,因為它可以檢測傳統內視鏡檢查或大腸鏡檢查無法發現的小腸內出血來源。小腸腫瘤的診斷是胃腸病學的一個挑戰,因為傳統的內視鏡設備進入小腸的途徑有限。膠囊內視鏡是檢查小腸良性和惡性的重要工具。它有助於早期診斷,並在其他影像檢查無法提供足夠的可視性或結論性結果時發揮重要作用。膠囊內視鏡的偏好很大程度上取決於進入和可視化小腸遠處區域的能力。克隆氏症的長期後續觀察至關重要,而 OGIB 則優先考慮確定出血來源的急性診斷能力。對於小腸腫瘤,早期、準確的檢測非常重要。
最終用途:在醫院中擴大使用案例膠囊內視鏡來處理需要多學科方法的複雜病例
門診手術中心是提供當天手術治療的醫療機構,包括診斷和預防程序。 ASC 越來越受到膠囊內視鏡檢查的青睞,因為它們不需要住院並提供方便且具有成本效益的服務。 ASC 因其患者周轉快、院內感染風險低以及提供專業護理的能力而受到青睞。醫院是各種內視鏡手術(包括膠囊內視鏡檢查)的主要場所。對於需要多學科方法或需要緊急干預的複雜病例,醫院是首選。該醫院擁有廣泛的基礎設施,包含各種診斷和治療服務,如果需要進一步治療,則結合膠囊內視鏡檢查治療結果進行。
區域洞察
在美洲,受先進的醫療基礎設施、研發和胃腸道疾病高盛行率的推動,美國是膠囊內視鏡的領先市場。膠囊內視鏡的採用得到了其他地區不常見的優惠報銷政策的支持。由於醫療保健支出和技術採用率的差異,加拿大和南美國家也對市場做出了輕微貢獻。亞太地區膠囊內視鏡市場正在快速成長,這主要是由於人口老化的加劇、醫療基礎設施的改善以及胃腸道疾病發病率的增加。日本、韓國和中國等國家處於領先地位,其中日本因其創新的醫療保健系統而成為膠囊內視鏡技術的較早採用者。歐洲、中東和非洲 (EMEA) 地區呈現出多元化的膠囊內視鏡市場。西歐國家擁有成熟的醫療保健部門,有強大的醫療保健系統和廣泛的保險計劃支持,並且膠囊內視鏡等新診斷技術的採用率很高。在中東國家,由於醫療投資的增加和醫療設施的現代化,對醫療保健服務和醫療設備(包括膠囊內視鏡)的需求正在增加。
FPNV定位矩陣
FPNV定位矩陣對於評估膠囊內視鏡市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對膠囊內視鏡市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭力評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.膠囊內視鏡市場規模及預測如何?
2.在膠囊內視鏡市場預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?
3.膠囊內視鏡市場的技術趨勢和法規結構是什麼?
4.膠囊內視鏡市場主要廠商的市場佔有率如何?
5.進入膠囊內視鏡市場的合適型態和策略手段是什麼?
[196 Pages Report] The Capsule Endoscopy Market size was estimated at USD 554.66 million in 2023 and expected to reach USD 606.57 million in 2024, at a CAGR 9.80% to reach USD 1,067.37 million by 2030.
Capsule endoscopy is a modern diagnostic tool that allows for the visualization and examination of the gastrointestinal tract using a pill-sized capsule equipped with a camera. This market comprises manufacturers, healthcare providers, and patients utilizing the device for gastrointestinal diagnosis. The increasing prevalence of gastrointestinal disorders globally and the significant adoption of minimally invasive surgical interventions contribute positively to market growth. Concerns associated with capsule retention rate, adverse effects, and incomplete small bowl examination results are significant hindrances in markets. Opportunities within this market involve growing initiatives to improve healthcare infrastructure and increase awareness of gastrointestinal disorders. In addition, technological advancements coupled with better-designed wireless capsules are expected to create growth in the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 554.66 million |
Estimated Year [2024] | USD 606.57 million |
Forecast Year [2030] | USD 1,067.37 million |
CAGR (%) | 9.80% |
Product: Growing adoption of capsule endoscopes due to their minimally invasive nature
Capsule endoscopes are tiny, pill-sized cameras that patients swallow. These devices travel through the gastrointestinal tract, capturing images and sending them wirelessly for medical diagnosis. These are preferred for their ability to visualize the small intestine, an area that is difficult to reach with traditional endoscopes. Patients opt for capsule endoscopes due to their minimally invasive nature, with no need for sedation. The ease of the procedure and the lack of discomfort are significant benefits, making it suitable for children and elderly patients. Systems in the context of capsule endoscopy include the necessary supporting hardware and software used to record, view, and analyze the data captured by the capsule endoscopes. Such systems consist of workstations, data recorders, receiver belts, and software for image analysis. These are critical for collecting and managing the vast amounts of data generated by capsule endoscopes. Advanced software helps in the detailed examination of images and supports better diagnosis. User-friendly interfaces are valued by healthcare providers for streamlining the endoscopic process.
Application: Expanding usage of capsule endoscopes for managing obscure gastrointestinal bleeding (OGIB)
Crohn's disease is a type of inflammatory bowel disease (IBD) that affects any part of the gastrointestinal tract. Capsule endoscopy is particularly beneficial in diagnosing and assessing the extent and activity of Crohn's disease, as it can visualize areas of the small intestine that are difficult to reach with traditional endoscopy procedures. The non-invasive nature of capsule endoscopy provides a more patient-friendly option for continuous monitoring of disease progression or response to therapy. Obscure gastrointestinal bleeding (OGIB) refers to bleeding that occurs from an unknown source in the gastrointestinal tract. Capsule endoscopy is critical in diagnosing OGIB, as it can detect bleeding sources in the small intestine that are not visible through traditional endoscopy or colonoscopy. Small intestine tumor diagnosis is a challenging area in gastrointestinal medicine due to the limited accessibility of the small intestine with conventional endoscopic equipment. Capsule endoscopy is a crucial tool in detecting benign and malignant tumors within the small intestine. It helps in early diagnosis and plays a vital role where other imaging studies don't provide adequate visibility or conclusive results. The preference for capsule endoscopy is shaped largely by its ability to access and visualize remote parts of the small bowel. With Crohn's Disease, the long-term monitoring aspect is paramount, while in OGIB, the acute diagnostic capability to identify the source of bleeding is the priority. For small intestine tumors, the emphasis is on early and accurate detection.
End-Use: Increasing usage of capsule endoscopes by hospitals for more complicated cases that require a multi-disciplinary approach
Ambulatory surgery centers are healthcare facilities that provide same-day surgical care, including diagnostic and preventive procedures. ASCs are increasingly preferred for capsule endoscopy because they offer convenient and cost-effective services without the need for hospital admission. The preference for ASCs stems from the expedited patient turnover, reduced risk of hospital-acquired infections, and their ability to provide specialized care. Hospitals serve as the primary setting for a wide range of endoscopic procedures, including capsule endoscopy. They are preferred for more complicated cases that require a multi-disciplinary approach or might require emergency intervention. Hospitals have a broad infrastructure that tends to incorporate various diagnostic and therapeutic services, which work in conjunction with capsule endoscopy outcomes if further treatment is needed.
Regional Insights
In the Americas, the United States is a key market for capsule endoscopy, driven by advanced healthcare infrastructure, a substantial focus on research and development, and a high prevalence of gastrointestinal diseases. The adoption of capsule endoscopy is supported by favorable reimbursement policies, less readily seen in other regions. Canada and South American countries also contribute to the market, though to a lesser extent due to variances in healthcare expenditure and technological adoption rates. The Asia-Pacific is witnessing rapid growth in the capsule endoscopy market, largely fueled by an increasing aging population, growing healthcare infrastructure, and rising incidences of gastrointestinal disorders. Countries such as Japan, South Korea, and China are at the forefront, with Japan featuring some of the earliest adopters of capsule endoscopy technology due to its innovation-friendly healthcare system. The Europe, Middle East, and Africa (EMEA) region presents a diverse market for capsule endoscopy. Western European countries have a mature healthcare sector with high adoption of novel diagnostic technologies, including capsule endoscopy, aided by strong healthcare systems and wide insurance coverage. In Middle Eastern countries, there is a growing demand for healthcare services and medical devices, including capsule endoscopy, driven by increasing healthcare investments and modernization of healthcare facilities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Capsule Endoscopy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Capsule Endoscopy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Capsule Endoscopy Market, highlighting leading vendors and their innovative profiles. These include AdvinHealthcare, Ambu A/S, Anx Robotica Corp., Biocam Sp. z o.o., Boston Scientific Corporation, CapsoVision Inc., Check-Cap Ltd. by Symetryx Corp., Chongqing Jinshan Science & Technology (Group) Co., Ltd, Covestro AG, Duomed Group, Fujifilm Holding Corporation, Intromedic co., Ltd, Medtronic PLC, MU Ltd., Olympus Corporation, RF Systems Lab, Shangxian Minimal Invasive Inc., and STERIS Corporation.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Capsule Endoscopy Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Capsule Endoscopy Market?
3. What are the technology trends and regulatory frameworks in the Capsule Endoscopy Market?
4. What is the market share of the leading vendors in the Capsule Endoscopy Market?
5. Which modes and strategic moves are suitable for entering the Capsule Endoscopy Market?